SCHEMBL26316767

SCHEMBL26316767

Cc1ccc(CCCCn2cccn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.47
HTT P42858 1/20 0.47
ALDH1A1 P00352 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 2/20 0.41
HSD11B1 P28845 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ATM Q13315 1/20 0.41
MITF O75030 1/20 0.40
POLB P06746 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
IGF1R P08069 1/20 0.40
ALOX15 P16050 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TLR8 Q9NR97 1/20 0.40
TLR7 Q9NYK1 1/20 0.40
GAA P10253 2/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22397978 0.84 ESR1 (0.47) ALDH1A1L3MBTL1KMT2AIGF1RALOX15
SCHEMBL22398139 0.83 SIGMAR1 (0.46) ALDH1A1L3MBTL1KMT2ARAB9ASIGMAR1
SCHEMBL26316512 0.80 ALDH1A1 (0.39) ALDH1A1L3MBTL1KMT2ANPC1RAB9A
SCHEMBL18461825 0.80 KMT2A (0.50) HTTALDH1A1L3MBTL1KMT2ANPC1
SCHEMBL10785390 0.79 ESR1 (0.44) HTTALDH1A1L3MBTL1KMT2ANPC1
SCHEMBL12321326 0.78 MAPT (0.60) HTTALDH1A1KMT2ANPC1RAB9A
SCHEMBL26316556 0.77 HRH1 (0.47) HRH1NPC1RAB9AATMSIGMAR1
SCHEMBL7100687 0.76 DAO (0.43) HTTALDH1A1L3MBTL1TLR8TLR7
SCHEMBL21321921 0.76 GAA (0.42) ALDH1A1L3MBTL1KMT2ANPC1RAB9A
Ammonia Solution, Strong SCHEMBL4845813 0.74 SKP2 (0.55) HTTALDH1A1L3MBTL1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357221-A1 HETEROCYCLIC MITOCHONDRIAL ACTIVITY INHIBITORS AND USES THEREOF UNIV MONTREAL (CA) 2023-11-09 US disclosed
US-11760754-B2 Heterocyclic mitochondrial activity inhibitors and uses thereof Université de Montréal (CA) 2023-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357221-A1 HETEROCYCLIC MITOCHONDRIAL ACTIVITY INHIBITORS AND USES THEREOF IDH2, TFAM, IDH1 HRH1 4019/4885HTT 2586/4885ALDH1A1 2036/4885
US-11760754-B2 Heterocyclic mitochondrial activity inhibitors and uses thereof IDH2, TFAM, NUTF2 HRH1 4175/4885HTT 2260/4885ALDH1A1 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.